Northern Trust’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,321
| Closed | -$10.6K | – | 4529 |
|
|
2025
Q3 | $10.6K | Hold |
2,321
| – | – | ﹤0.01% | 4405 |
|
|
2025
Q2 | $9.08K | Hold |
2,321
| – | – | ﹤0.01% | 4377 |
|
|
2025
Q1 | $9.38K | Sell |
2,321
-1,352
| -37% | -$6.21K | ﹤0.01% | 4391 |
|
|
2024
Q4 | $27.8K | Sell |
3,673
-477
| -11% | -$6.69K | ﹤0.01% | 4343 |
|
|
2024
Q3 | $100K | Sell |
4,150
-30
| -0.7% | -$845 | ﹤0.01% | 4055 |
|
|
2024
Q2 | $175K | Sell |
4,180
-120
| -3% | -$6.29K | ﹤0.01% | 3900 |
|
|
2024
Q1 | $278K | Sell |
4,300
-296
| -6% | -$15K | ﹤0.01% | 3769 |
|
|
2023
Q4 | $208K | Buy |
4,596
+2,254
| +96% | +$103K | ﹤0.01% | 3888 |
|
|
2023
Q3 | $102K | Sell |
2,342
-20
| -0.8% | -$1.17K | ﹤0.01% | 4010 |
|
|
2023
Q2 | $171K | Sell |
2,362
-7
| -0.3% | -$570 | ﹤0.01% | 3883 |
|
|
2023
Q1 | $180K | Buy |
2,369
+158
| +7% | +$12.7K | ﹤0.01% | 3900 |
|
|
2022
Q4 | $213K | Hold |
2,211
| – | – | ﹤0.01% | 3840 |
|
|
2022
Q3 | $249K | Buy |
2,211
+366
| +20% | +$42.6K | ﹤0.01% | 3770 |
|
|
2022
Q2 | $234K | Sell |
1,845
-42
| -2% | -$3.69K | ﹤0.01% | 3843 |
|
|
2022
Q1 | $132K | Hold |
1,887
| – | – | ﹤0.01% | 4263 |
|
|
2021
Q4 | $135K | Hold |
1,887
| – | – | ﹤0.01% | 4330 |
|
|
2021
Q3 | $98K | Sell |
1,887
-98
| -5% | -$5.84K | ﹤0.01% | 4404 |
|
|
2021
Q2 | $123K | Sell |
1,985
-1,494
| -43% | -$83.9K | ﹤0.01% | 4313 |
|
|
2021
Q1 | $257K | Sell |
3,479
-1,169
| -25% | -$112K | ﹤0.01% | 4024 |
|
|
2020
Q4 | $426K | Buy |
4,648
+587
| +14% | +$49.2K | ﹤0.01% | 3760 |
|
|
2020
Q3 | $141K | Sell |
4,061
-59
| -1% | -$1.41K | ﹤0.01% | 3884 |
|
|
2020
Q2 | $59K | Hold |
4,120
| – | – | ﹤0.01% | 4027 |
|
|
2020
Q1 | $78K | Hold |
4,120
| – | – | ﹤0.01% | 3869 |
|
|
2019
Q4 | $81K | Sell |
4,120
-1
| -0% | -$20 | ﹤0.01% | 3970 |
|
|
2019
Q3 | $79K | Hold |
4,121
| – | – | ﹤0.01% | 3965 |
|
|
2019
Q2 | $89K | Hold |
4,121
| – | – | ﹤0.01% | 3992 |
|
|
2019
Q1 | $124K | Buy |
4,121
+43
| +1% | +$1.32K | ﹤0.01% | 3875 |
|
|
2018
Q4 | $128K | Sell |
4,078
-56
| -1% | -$1.7K | ﹤0.01% | 3874 |
|
|
2018
Q3 | $124K | Hold |
4,134
| – | – | ﹤0.01% | 3985 |
|
|
2018
Q2 | $134K | Sell |
4,134
-331
| -7% | -$11K | ﹤0.01% | 3956 |
|
|
2018
Q1 | $132K | Buy |
4,465
+2,951
| +195% | +$75K | ﹤0.01% | 3911 |
|
|
2017
Q4 | $33K | Sell |
1,514
-70
| -4% | -$1.53K | ﹤0.01% | 4115 |
|
|
2017
Q3 | $34K | Hold |
1,584
| – | – | ﹤0.01% | 4104 |
|
|
2017
Q2 | $33K | Buy |
1,584
+188
| +13% | +$3.77K | ﹤0.01% | 4128 |
|
|
2017
Q1 | $32K | Hold |
1,396
| – | – | ﹤0.01% | 4103 |
|
|
2016
Q4 | $28K | Buy |
1,396
+12
| +0.9% | +$242 | ﹤0.01% | 4071 |
|
|
2016
Q3 | $27K | Hold |
1,384
| – | – | ﹤0.01% | 4079 |
|
|
2016
Q2 | $18K | Hold |
1,384
| – | – | ﹤0.01% | 4127 |
|
|
2016
Q1 | $19K | Hold |
1,384
| – | – | ﹤0.01% | 4138 |
|
|
2015
Q4 | $21K | Hold |
1,384
| – | – | ﹤0.01% | 4168 |
|
|
2015
Q3 | $22K | Buy |
+1,384
| New | +$20.8K | ﹤0.01% | 4175 |
|
|
2015
Q2 | – | Sell |
-1,085
| Closed | -$14K | – | 4277 |
|
|
2015
Q1 | $14K | Sell |
1,085
-74
| -6% | -$1.09K | ﹤0.01% | 4245 |
|
|
2014
Q4 | $17K | Hold |
1,159
| – | – | ﹤0.01% | 4187 |
|
|
2014
Q3 | $16K | Hold |
1,159
| – | – | ﹤0.01% | 4223 |
|
|
2014
Q2 | $19K | Hold |
1,159
| – | – | ﹤0.01% | 4180 |
|
|
2014
Q1 | $23K | Buy |
+1,159
| New | +$22K | ﹤0.01% | 4110 |
|
Other funds holding PRPH
SC
SG
CA
Northern Trust's PRPH Position: Q4 2025 in Review
Northern Trust sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 2,321 shares — an estimated $10.6K sold.
Northern Trust first reported a position in PRPH in Q1 2014 and held it in 46 quarters. The position peaked at $426K in Q4 2020. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.
- Northern Trust reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
- Northern Trust sold 2,321 ProPhase Labs shares in Q4 2025, an estimated $10.6K.
- Northern Trust first reported a position in ProPhase Labs in Q1 2014 and held it in 46 quarters.
- Northern Trust's ProPhase Labs position peaked at $426K in Q4 2020.
- 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.
Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.